People
-
UK dry powder dispensing company VaryDose has announced the appointment of Philippe Rogueda as its Chief Technology Officer. According to the company, “Philippe brings with him many years’ experience and expertise in the powder handling… Read more . . .
-
According to MannKind Corporation, it has completely resolved arbitration initiated by a lawsuit filed by its former Senior Director – GCP – Regulatory Affairs, John Arditi, in 2010. Arditi, who had been responsible for MannKind’s… Read more . . .
-
The prize for the best poster presented at PowderFlow 2011 was awarded to Hanne Kinnunen, a PhD student in the Pharmaceutical Surface Science Research Group, Department of Pharmacy and Pharmacology at the University of Bath,… Read more . . .
-
Bloomberg has published an article about GSK’s overhaul of its R&D organization that describes former head of the allergic inflammation discovery performance unit Roberto Solari as “one of the casualties of the company’s new approach… Read more . . .
-
The New York Microscopical Society has recognized Malvern Instruments Chief Technology Officer E. Neil Lewis with its Ernst Abbe Memorial Award for outstanding contributions to the science of microscopy. The society specifically cited Dr. Lewis’s… Read more . . .
-
James Vaughan has retired as Vice President and General Manager of 3M Drug Delivery Systems, and the company has announced the appointment of James Ingebrand to replace him. Ingebrand has been with 3M for 27… Read more . . .
-
Ken Cunningham, who recently joined the board of UK pharmaceutical and particle engineering company Prosonix, will lead the company’s new scientific advisory board. Joining Cunningham on Prosonix’s SAB are: Peter Barnes, Professor of Thoracic Medicine… Read more . . .
-
Prospect Venture Partners, Lighthouse Capital Partners, and Covington Venture Fund will provide a total of $4.5 million in Series A financing to Azelon Pharmaceuticals, formerly Zelos Therapeutics, for continued clinical development of Azelon’s ZT-034 teriparatide… Read more . . .
-
Inhaled pharmaceuticals developer Pulmatrix has named former Pfizer VP Michael Yeadon as an advisor to its management team and as the newest member of its scientific advisory board. Yeadon joined Pfizer in 1995 and was… Read more . . .
-
As Nycomed officially becomes a wholly owned subsidiary of Takeda Pharmaceutical Company, Takeda has named Frank Morich as the new Nycomed CEO. Morich will also continue in his current position as Executive VP (EVP) of… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
December 9-December 11: DDL 2026, Edinburgh, Scotland